Skip to main content

Search Site

Think You Have ADHD? What Your Ontario Family Doctor Can Actually Do

Erik Bos Date : 01 Apr, 2026 Categories : Mental Health Tags : ADHD , mental health
Young adult reflecting on ADHD symptoms at desk

Between 2015 and 2023, new stimulant prescriptions in Ontario jumped by 157%. Not a gradual climb. A near-tripling. And the most striking part isn’t the overall number. It’s who’s getting them. Stimulant prescriptions for women aged 25 to 44 increased by 421%. For women aged 18 to 24, the increase was 369%. A parallel population study from British Columbia tracked new adult ADHD diagnoses from 2013 to 2023 and found that the pre-pandemic monthly rate of 8.8 per 100,000 rocketed to 34.8 in the post-pandemic period, a fourfold increase. Women made up 60% of those post-pandemic cases.

Something clearly shifted. But what exactly, and what does it mean if you’re sitting in Ontario reading this and wondering whether your own scattered attention, chronic disorganization, or inability to finish anything might actually be ADHD?

The short answer is that the surge is real, the condition is real, and your family doctor can do far more about it than most people realize. The longer answer involves a tangle of pandemic-era lifestyle disruption, decades of missed diagnoses in women, a social media awareness explosion that’s partly helpful and partly misleading, and an Ontario healthcare system that makes getting a specialist appointment feel like applying for a mortgage.

Why Women Are Getting Diagnosed Now

For decades, ADHD research was built around hyperactive boys in elementary school classrooms. The diagnostic criteria reflected that population, and the referral pipeline flowed accordingly. Girls who daydreamed through class instead of bouncing off walls, who compensated with perfectionism or people-pleasing, who swallowed their struggles as personal failure rather than externalizing them as disruptive behavior, mostly got missed. An analysis across more than 20 studies found that only one in four adolescent girls received ADHD medication prescriptions, compared to three in four boys.

The consequences of that gap accumulated quietly for years. Women who were never identified as children developed anxiety, depression, eating disorders, and chronic self-doubt, often receiving treatment for those secondary conditions without anyone examining what was underneath them. A 2025 study in Frontiers in Global Women’s Health investigated gender-based differences in how adults endorsed ADHD symptoms using the DIVA-5 diagnostic interview and found that women’s presentations were reliably interpreted through a different lens than men’s, even by clinicians specifically assessing for ADHD. Women showed the same functional impairment but described it in language that mapped less neatly onto traditional checklists.

What the pandemic did was strip away the coping mechanisms. Working from home eliminated the external structure of offices. Lockdowns removed social routines. Suddenly, people who’d been white-knuckling their way through life with undiagnosed attention deficits couldn’t mask anymore. The SickKids and ICES Ontario study documented the acceleration starting in 2020: stimulant prescriptions increased 28% per year between 2020 and 2023, compared to 7% per year from 2015 to 2019. The pandemic didn’t create ADHD. It created conditions where ADHD became impossible to hide.

The Ontario Assessment Bottleneck

If your first instinct is to ask your family doctor for a referral to a psychiatrist, brace yourself. Ontario has about 15.7 psychiatrists per 100,000 residents, and more than half of them are approaching retirement age. CAMH, the province’s largest mental health institution, quoted wait times of 14 to 18 months for adult intake as recently as 2024. Outside Toronto, the waits are often longer. For a condition where early intervention meaningfully changes life outcomes, an 18-month queue isn’t just inconvenient; it’s a system failure that costs patients relationships, jobs, and years of unnecessary suffering.

Private ADHD assessments exist and can be completed in weeks rather than months, but they run between $2,000 and $4,500, which prices out the exact population most likely to need help: young adults who are underemployed or struggling financially because their undiagnosed ADHD has already impacted their career trajectory. The irony is bitter and well-documented.

Here’s what fewer people know: you don’t necessarily need a psychiatrist. Family doctors in Ontario can diagnose ADHD. They can prescribe stimulant medications. They can manage ongoing treatment. And the entire process is covered by OHIP. The College of Physicians and Surgeons of Ontario doesn’t restrict ADHD prescribing to specialists, and the Ontario Family Physicians best practices guidelines published in 2024 explicitly support primary care management of adult ADHD. Some GPs are more comfortable with this than others, and complex cases with multiple psychiatric comorbidities may still benefit from specialist input. But the idea that only a psychiatrist can diagnose and treat adult ADHD is a myth that’s actively harming access to care.

What a Good Assessment Looks Like

A family doctor assessing for adult ADHD will typically start with a validated screening tool. The Adult ADHD Self-Report Scale, usually called the ASRS, takes about five minutes and produces a score that indicates whether a full evaluation is warranted. The DIVA-5, a longer structured interview, walks through childhood and adult symptoms with specific examples and is considered the gold standard for clinical diagnosis. Your GP might do the ASRS in-office and then schedule a longer follow-up appointment for a more thorough assessment, or they might use the ASRS as a starting point and add their own clinical judgment based on your history.

The most useful thing you can bring to that appointment is preparation. Write down specific examples of how attention difficulties affect your daily life: missed deadlines, forgotten appointments, starting eight projects and finishing none, losing your keys three times before leaving the house. Note how long these patterns have been present. ADHD is a developmental condition, which means symptoms need to have been present since childhood, even if nobody recognized them at the time. If your parents or siblings can corroborate that you were always the scattered one in the family, that context helps. Old report cards with comments like “bright but doesn’t apply herself” or “capable but inconsistent” are useful clinical evidence, more than most people realize.

Your doctor should also screen for conditions that mimic or co-occur with ADHD: anxiety, depression, sleep disorders, thyroid dysfunction. This isn’t about gatekeeping. It’s about making sure the treatment plan addresses the right problem. Iron deficiency, sleep apnea, and chronic stress can all produce attention and concentration symptoms that look very similar to ADHD on the surface, and a good clinician will consider the full picture before reaching for a prescription pad. Baseline bloodwork can rule out several of these mimics in a single lab visit.

Medication: What Works, What’s Available, What’s Not

Stimulant medications, methylphenidate (Ritalin, Concerta) and amphetamine-based drugs (Adderall, Vyvanse), remain the first-line pharmacological treatment for adult ADHD across every major clinical guideline. They work for roughly 70-80% of patients, typically producing noticeable improvements within days to weeks. The effect sizes for stimulants on ADHD symptom reduction are among the largest in all of psychiatry, which is one reason the field has moved toward earlier and more proactive treatment rather than the “wait and see” approach that dominated previous decades.

The catch is availability. Canada has experienced rolling stimulant shortages since 2022, driven by manufacturing issues at major producers like Teva Pharmaceuticals and DEA production quotas in the United States that constrain the global supply of active pharmaceutical ingredients. Adderall XR formulations appeared on provincial drug shortage lists in 2025 and 2026. Vyvanse (lisdexamfetamine) has had intermittent supply disruptions. Your doctor may need to switch between formulations based on what’s actually stocked at your pharmacy, which is frustrating but manageable with good communication between your GP and pharmacist.

For patients who can’t tolerate stimulants or who have contraindications (uncontrolled hypertension, certain cardiac conditions, active substance use disorders), non-stimulant options include atomoxetine (Strattera) and guanfacine. They work through different mechanisms, take longer to reach full effect, and generally produce smaller improvements than stimulants, but they’re real options with solid evidence behind them.

A recent cardiovascular safety review in The Lancet Psychiatry (2025) examined the hemodynamic effects of all ADHD medications across age groups. The takeaway: all pharmacological treatments for ADHD can affect blood pressure and pulse, not just stimulants. The practical implication is that your doctor should check your blood pressure and heart rate at baseline, shortly after starting medication, and periodically during treatment. This is standard care, not cause for alarm.

What TikTok Got Right (and What It Didn’t)

By February 2025, there were 3.9 million posts on TikTok using the hashtag #ADHD. A 2025 study in PLOS ONE found that fewer than half of the claims about ADHD symptoms in popular TikTok videos aligned with the diagnostic criteria in the DSM. A separate analysis determined that 92% of videos using #adhdtest were misleading, with 71% emphasizing transdiagnostic symptoms, meaning things like forgetfulness, restlessness, and difficulty concentrating that show up in a dozen different conditions, not just ADHD.

That’s the bad news. The good news is harder to quantify but equally real. People who spent more than an hour daily on TikTok were far more likely to seek professional ADHD diagnosis, and a substantial portion of those people turned out to actually have the condition. For women in their 20s and 30s who were told their whole lives that they were lazy, anxious, or just not trying hard enough, a 60-second video describing exactly what their internal experience felt like was sometimes the first moment anyone had ever named what was happening in their brains. The medium is imperfect. The awareness it generated wasn’t.

The responsible position, and the one increasingly reflected in clinical literature, is that social media is a lousy diagnostic tool but a powerful case-finding mechanism. If a TikTok video made you think you might have ADHD, the correct next step is not self-diagnosis. It’s a clinical conversation. Bring it up with your family doctor. There’s no shame in saying “I’ve been reading about adult ADHD and I recognize a lot of myself in the descriptions.” A good doctor will take that seriously and assess properly.

Beyond Medication: What the Evidence Actually Supports

A 2025 systematic review and network meta-analysis encompassing 37 randomized controlled trials with 2,289 participants compared ten different non-pharmacological therapies for adult ADHD. Cognitive behavioral therapy came out on top for patients with emotional comorbidities like anxiety and depression alongside their ADHD. Mindfulness-based cognitive therapy performed well for patients without significant comorbidities. A separate 2025 RCT found that a CBT protocol combining organization/activation skills with mindfulness training produced measurably better outcomes on activation measures than standard approaches.

One encouraging practical finding: a six-session CBT protocol was found to be as effective as a 12-session protocol for ADHD symptom improvement at both post-treatment and follow-up. That matters because access to therapists is its own bottleneck, and knowing that shorter evidence-based programs work comparably to longer ones makes the whole intervention more feasible.

The evidence for physical exercise as a standalone ADHD intervention is thinner than many wellness influencers suggest. There’s biological plausibility: exercise increases dopamine and norepinephrine, the same neurotransmitters targeted by stimulant medication. But the RCT evidence specifically in adults with ADHD is limited, and what exists is hard to interpret because exercise is often bundled with other interventions. What you can say honestly is that exercise helps with mood, sleep, and cognitive function broadly, and that those benefits are especially valuable for people managing ADHD. Just don’t expect a jog to replace your Vyvanse.

The Case for a Family Doctor Who Knows You

If there’s a consistent thread running through the ADHD diagnostic experience, it’s that continuity matters. The women who got missed as children got missed because nobody was tracking the pattern across years. The adults struggling now are struggling partly because walk-in clinic visits don’t build a longitudinal picture. A family doctor who sees you regularly can spot the difference between situational stress and a lifelong attention pattern. They can trial medication, adjust doses across visits, monitor side effects, and coordinate with a therapist without requiring you to re-tell your life story at every appointment.

Ontario’s primary care crisis makes finding a family doctor its own challenge. We’ve written about how the healthcare system works and what your options are. But if you do have a GP, or when you find one, adult ADHD is absolutely something worth raising. The assessment is covered. The medication is covered. The management is within their scope. And the difference between struggling undiagnosed and getting appropriate treatment is, for many people, the difference between a life that feels impossibly hard and one that finally makes sense.

If you’re concerned about your mental health more broadly or want to understand what preventive care looks like when you actually have a doctor, those are good starting points.

References

  1. Sharp rise in ADHD stimulant prescriptions in Ontario, research finds. SickKids/ICES Ontario Study, 2025. www.sickkids.ca/en/news/archive/2025/sharp-rise-in-adhd-stimulant-prescriptions-in-ontario-research-finds/

  2. Trends of incident adult ADHD diagnoses before, during and after the pandemic in British Columbia (2013-2023). The Lancet Regional Health Americas, 2025. DOI: 10.1016/j.lana.2025.100973 www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00233-9/fulltext

  3. Bias by gender: exploring gender-based differences in endorsement of ADHD symptoms among adult patients. Frontiers in Global Women’s Health, 2025. DOI: 10.3389/fgwh.2025.1549028 pmc.ncbi.nlm.nih.gov/articles/PMC11965619/

  4. Best practices for treating and diagnosing ADHD in primary care. Ontario Family Physicians, 2024. ontariofamilyphysicians.ca/wp-content/uploads/2024/09/2024-09-18-Practising-Well-CoP-Slides.pdf

  5. Comparative cardiovascular safety of medications for ADHD: systematic review and network meta-analysis. The Lancet Psychiatry, 2025. DOI: 10.1016/S2215-0366(25)00062-8 www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00062-8/abstract

  6. Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: systematic review and network meta-analysis. Frontiers in Psychiatry, 2025. DOI: 10.3389/fpsyt.2025.1516878 www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1516878/full

  7. Cognitive behavioral therapy for ADHD predominantly inattentive presentation: randomized controlled trial. Frontiers in Psychiatry, 2025. DOI: 10.3389/fpsyt.2025.1564506 www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1564506/full

  8. A double-edged hashtag: Evaluation of #ADHD-related TikTok content. PLOS ONE, 2025. DOI: 10.1371/journal.pone.0319335 journals.plos.org/plosone/article?id=10.1371/journal.pone.0319335

  9. How evidence-based is the “hashtag ADHD test”: content analysis of TikTok videos on ADHD screening. Australasian Psychiatry, 2025. DOI: 10.1177/10398562241291956 journals.sagepub.com/doi/abs/10.1177/10398562241291956

  10. ADHD Medications and Long-Term Risk of Cardiovascular Diseases. JAMA Psychiatry, 2024. DOI: 10.1001/jamapsychiatry.2023.4294 jamanetwork.com/journals/jamapsychiatry/fullarticle/2811812

  11. Psychiatric Assessment Wait Times in Toronto: 2025 Updates. Dynamic Health Clinic. www.dynamichealthclinic.ca/blogs/psychiatric-assessment-wait-times-toronto-2025